JCB logo
Keystone Symposia
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 5 February 2001. doi:10.1083/jcb.152.3.645
This Article
Right arrow Full Text
Right arrow PDF (Full Text)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arin, M. J.
Right arrow Articles by Roop, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arin, M. J.
Right arrow Articles by Roop, D. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0021-9525/2001/2/645/ $5.00
The Journal of Cell Biology, Volume 152, Number 3, February 5, 2001 645-650


Report

Focal Activation of a Mutant Allele Defines the Role of Stem Cells in Mosaic Skin Disorders

Meral J. Arina, Mary Ann Longleya, Xiao-Jing Wanga,b, and Dennis R. Roopa,b
a Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030
b Department of Dermatology, Baylor College of Medicine, Houston, Texas 77030

Correspondence to: Dennis R. Roop, Baylor College of Medicine, Department of Molecular and Cellular Biology, One Baylor Plaza, Houston, TX 77030. Tel:(713) 798-4966 Fax:(713) 798-3800 E-mail:roopd{at}bcm.tmc.edu.

Stem cells are crucial for the formation and maintenance of tissues and organs. The role of stem cells in the pathogenesis of mosaic skin disorders remains unclear. To study the molecular and cellular basis of mosaicism, we established a mouse model for the autosomal-dominant skin blistering disorder, epidermolytic hyperkeratosis (MIM 113800), which is caused by mutations in either keratin K1 or K10. This genetic model allows activation of a somatic K10 mutation in epidermal stem cells in a spatially and temporally controlled manner using an inducible Cre recombinase. Our results indicate that lack of selective pressure against certain mutations in epidermal stem cells leads to mosaic phenotypes. This finding has important implications for the development of new strategies for somatic gene therapy of dominant genodermatoses.

Key Words: epidermolytic hyperkeratosis, keratins, Cre recombinase, mosaic skin disease, gene therapy


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents